COMMUNIQUÉS West-GlobeNewswire

-
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo
30/07/2025 -
PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025
30/07/2025 -
Immutep Quarterly Activities Report Q4 FY25
30/07/2025 -
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
30/07/2025 -
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology
30/07/2025 -
Marker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
30/07/2025 -
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
30/07/2025 -
IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
30/07/2025 -
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
30/07/2025 -
Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
30/07/2025 -
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025
30/07/2025 -
Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing
30/07/2025 -
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
30/07/2025 -
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
30/07/2025 -
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update
30/07/2025 -
Tenaya Receives Positive Safety Reviews from Independent DSMBs to Advance Both TN-201 and TN-401 Gene Therapy Clinical Trials as Designed
30/07/2025 -
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
30/07/2025 -
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
30/07/2025 -
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth
30/07/2025
Pages